GSK (GSK) Profit Margin (2006 - 2026)
GSK (GSK) profit margin from Mar 31, 2006 to Mar 31, 2026. The current GSK (GSK) profit margin is 22.77%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of GSK (GSK)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | 17.50% | +113.21% |
| 2024 | 8.21% | -49.49% |
| 2023 | 16.25% | -68.14% |
| 2022 | 51.00% | +187.24% |
| 2021 | 17.76% | -24.78% |
| 2020 | 23.61% | +71.54% |
| 2019 | 13.76% | +17.07% |
| 2018 | 11.75% | +131.62% |
| 2017 | 5.08% | +55.20% |
| 2016 | 3.27% | -90.71% |
| 2015 | 35.20% | +193.87% |
| 2014 | 11.98% | -41.59% |
| 2013 | 20.51% | +20.49% |
| 2012 | 17.02% | -11.39% |
| 2011 | 19.21% | +233.79% |
| 2010 | 5.76% | -70.48% |
| 2009 | 19.50% | +3.17% |
| 2008 | 18.90% | -17.67% |
| 2007 | 22.95% | -1.08% |
| 2006 | 23.20% | N/A |
Comparison GSK (GSK) profit margin with competitors
GSK (GSK) profit margin is 22.77%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | 50.15% | +120.26% |
| LLY | Lilly(Eli) & Company | 37.36% | +64.09% |
| GILD | Gilead Sciences Inc | 29.04% | +27.55% |
| NVS | Novartis AG | 23.34% | +2.51% |
| BMY | Bristol-Myers Squibb Company | 23.30% | +2.33% |
| JNJ | Johnson & Johnson | 21.76% | -4.43% |
| AMGN | AMGEN Inc | 21.11% | -7.28% |
| AZN | Astrazeneca plc | 20.15% | -11.50% |
| PFE | Pfizer Inc | 18.59% | -18.35% |
| SNY | Sanofi | 14.35% | -36.97% |
| BIIB | Biogen Inc | 12.89% | -43.39% |
| OGN | Organon & Company | 10.00% | -56.08% |
| ABBV | Abbvie Inc | 4.63% | -79.66% |
| GRFS | Grifols SA | 4.29% | -81.16% |